Magnesium barrier membranes have emerged as biodegradable alternatives for guided bone regeneration (GBR), but their clinical performance and implications for polymer-based designs remain uncertain. This systematic review synthesized human evidence on magnesium barriers used in implant-related GBR, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (PROSPERO CRD420261456259). Five bibliographic databases and supplementary sources were searched; eligible studies underwent narrative synthesis, Joanna Briggs Institute appraisal, and outcome-level Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment. Sixteen publications were included, comprising case reports, case series, and observational studies; no randomized controlled trials were identified. Reported outcomes included radiographic hard tissue gains, subsequent implant placement, and satisfactory healing in selected clinical settings. However, heterogeneous protocols, limited follow-up, and concomitant interventions prevented attribution of benefits to magnesium alone. Membrane exposure and clinically detected gas were reported, although corrosion kinetics, gas composition, and long-term implant outcomes were insufficiently characterized. All 11 GRADE-assessed outcomes had very low certainty. No included clinical study evaluated an integrated polymer-coated magnesium barrier or magnesium–polymer composite membrane. Current evidence supports clinical feasibility but not comparative effectiveness. Polymer-based modifications warrant further investigation through material characterization and controlled clinical studies.